AAAAAA
Results:
1-7
|
Results: 7
Authors:
CASS I
RUNOWICZ CD
Citation: I. Cass et Cd. Runowicz, NONHORMONAL ALTERNATIVES TO TREATING MENOPAUSAL SYMPTOMS, American journal of managed care, 4(5), 1998, pp. 732-738
Authors:
CASS I
RUNOWICZ CD
Citation: I. Cass et Cd. Runowicz, MENOPAUSE AND CONTROVERSIES IN HORMONE REPLACEMENT THERAPY, American journal of managed care, 4(2), 1998, pp. 257-262
Authors:
CASS I
KUO DY
FIELDS AL
RUNOWICZ CD
GOLDBERG GL
Citation: I. Cass et al., PROFOUND THROMBOCYTOPENIA IN PREVIOUSLY TREATED PATIENTS WITH RECURRENT OVARIAN-CARCINOMA RECEIVING TOPOTECAN, Gynecologic oncology, 69(2), 1998, pp. 175-176
Authors:
MULLOKANDOV M
CASS I
ACHARY PM
KLINGER HP
Citation: M. Mullokandov et al., ASSIGNMENT OF ACTBP8 (ALIAS ACTBP2) WITH IN OR CLOSE TO HUMAN-CHROMOSOME BAND 6Q13 USING A RADIATION HYBRID PANEL, Cytogenetics and cell genetics, 78(1), 1997, pp. 46-47
Authors:
CASS I
RESNIK E
CHAMBERS JT
CHAMBERS SK
CARCANGIU ML
KOHORN EI
SCHWARTZ PE
Citation: I. Cass et al., COMBINATION CHEMOTHERAPY WITH ETOPOSIDE, CISPLATIN, AND DOXORUBICIN IN MIXED MULLERIAN TUMORS OF THE ADNEXA, Gynecologic oncology, 61(3), 1996, pp. 309-314
Authors:
TAYLOR HS
CASS I
LANG R
Citation: Hs. Taylor et al., BONE LOSS IN KALLMANN-SYNDROME, Obstetrics and gynecology, 88(4), 1996, pp. 734-734
Authors:
FISHMAN DA
VISCARELLO RR
CASS I
SCHWARTZ PE
Citation: Da. Fishman et al., EFFECT OF COMBINATION CHEMOTHERAPY WITH CISPLATIN AND CYCLOPHOSPHAMIDE ON HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 SURROGATE MARKERS IN A PATIENT WITH ADVANCED EPITHELIAL OVARIAN-CANCER, Gynecologic oncology, 57(1), 1995, pp. 105-108
Risultati:
1-7
|